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Viral infections in horses in Argentina: an overview
based on laboratory results
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Viral infections are a permanent threat for the equine industry
worldwide. In the present work we summarized the information,
regarding viral diseases of horses, obtained in our laboratory in
the last three years (2013-2015). During this period, 260 tissue
samples of abortions from 150 breeding farms; 83 nasopharyn-
geal swabs from 11 outbreaks of respiratory disease in foals and
808 from horses in the pre-export quarantine; 139 stools from 27
cases of diarrhea in foals; 112 semen samples from Equine
Arteritis virus (EAV) seropositive stallions and 8 central nervous
system (CNS) samples, were submitted for virological studies.
Serum samples were submitted for antibody detection of EAV (n:
13,800) andWest Nile Virus (WNV) (N: 5,482) from horses in pre-
import/export quarantine and from an EAV surveillance program
on registered (Stud book, Fomento Equino and Sociedad Rural
Argentina) stallions. The diagnosis approach was done by virus
isolation on tissue culture or embrionated eggs, and also by
detection of viral genome by PCR. Seroneutralization and MAC
ELISA were used for EAV and WNV antibody detection, respec-
tively. The described diagnostic tests were conducted following
the recommendations of the World Organization for Animal
Health (OIE). Equid herpesvirus 1 (EHV1) was detected in 5% (13/
260) of the abortions, and in 5 premises this infection generated
multiple fetal losses (abortion storms). All EHV1 were character-
ized as the non-neuropathogenic (A2254) variant. Equid herpes-
virus 4 was registered in 36% of the cases of respiratory disease in
foals. Influenza virus was not detected in none of the nasopha-
ryngeal swabs analyzed. Diarrhea in young foals due to Rotavirus
infection was detected in 48% (13/27) of the cases. EAV was not
found in the abortion cases or in the semen samples analyzed.
Rabies virus was the cause of neurological disease and death in
horses occurred in Salta province, an endemic area of vampire
bats (Desmodus rotundus). The virus was characterized as anti-
genic variant 3 (vampire). EAV serology demonstrated that 3%0737-0806/$ e see front matter.(356/13,800) of the samples analyzed were positive. The EAV
positive horses had been either related with the EAV outbreak
occurred in Argentina in 2010, or vaccinated, or imported as
vaccinated. No “new” EAV positive horses were detected after
August 2010. No samples tested positive forWNVwere found. The
data presented here showed that the horse population in
Argentina is exposed to several viral infections; thus, the impor-
tance of preventive and control measures as well as the benefits of
surveillance programs is emphasized.
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Equine Infectious Anemia (EIA) is a disease of great concern for
the equine industry worldwide. EIA virus (EIAV) infection can
result in either an acute or chronic (swamp fever) disease that
typically transitions to a life-long, inapparent (asymptomatic)
infection. Diagnosis is based on serological testing, being the agar
gel immunodiffusion test (AGID) the OIE prescribed test for in-
ternational trade of horses. To date, the detection of EIAV in the
blood by molecular diagnostic assays (e.g. quantitative real-time
RT-PCR) has not been implemented for routine diagnosis.
Recently, a fluorescent probe hydrolysis-based insulated
isothermal PCR (iiPCR) integrated with an optical detection
module (POCKIT TM) has been validated for on-site detection of
several bacterial and viral infections of veterinary interest in
clinical specimens. The aim of this work was to evaluate the
performance of an iiRT-PCR targeting the 50LTR+gag gene of EIAV
genome using the POCKITTM platform. Clinical samples included
serum, whole blood and buffy coat collected from 165 horses
distributed in an endemic (n¼53), a sporadic (n¼92), and a free
(n¼20) EIA zone based on previous prevalence studies performed
in Argentina. None of the horses included in the study showed
clinical signs of disease at the time of sampling. Serum samples
were tested by AGID, while whole blood and buffy coat samples
were tested by the newly developed EIAV iiRT-PCR and a previ-
ously described EIAV real-time PCR (qPCR) assay. The sensitivity
of the EIAV iiRT-PCR assay to detect infected horses was assessed
on whole blood and buffy coat samples, and compared with the
AGID test. A total of 56 and 109 serum samples were AGID positive
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PCR detected EIAV nucleic acid in 31/56 AGID positive samples,
while 108/109 AGID negative samples tested negative by iiRT-
PCR. Total agreement was 84.24%. When whole blood samples
were evaluated, a total of 16 iiRT-PCR positive and 15 iiRT-PCR
negative out of 31 AGID positive samples were obtained. Addi-
tionally, EIAV nucleic acid was not detected in 25 AGID negative
samples .Total agreement was 73.21% for this sample type. When
evaluating the accuracy of EIAV iiRT-PCR and qPCR, 28/165 and
130/165 buffy coat samples tested positive and negative by both
assays, respectively. Five iiRT-PCR positive samples were negative
by qPCR and two qPCR positive samples were negative by iiRT-
PCR. Thus, EIAV iiRT-PCR showed more than 95% agreement with
qPCR results. It has been demonstrated that the absence of clinical
signs is correlated with very low, frequently undetectable
viremia. Therefore, EIAV iiRT-PCR appears to be a promising tool
to identify infected horses including those experiencing low
infectivity titers in blood. Furthermore, as initial EIAV replication
rates are frequently high, recently infected equids pose a
considerable transmission risk long before seroconversion. In our
study, a horse was determined seronegative by AGID, but was
identified as EIAV infected by iiRT-PCR. Thus, EIAV iiRT-PCR could
be considered as an alternative diagnostic tool in the imple-
mentation of control strategies during an EIA outbreak in the low
prevalence area of our country.
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Equine arteritis virus (EAV) is the cause of equine viral arteritis,
a systemic viral disease of equids that is characterized by signsTable 1
Diagnostic performance of previous EAV ELISAs
Assay format, number sera tested Diagnostic sensitivity Diagnostic specificity Reference
Indirect ELISA (gp5+N+M), 187 92.3, 57.1% 100% J Virol Methods 76:127-37
Indirect ELISA (peptide, N and replicase), 200 99% 71% J Virol Methods 73:175-83
Indirect ELISA (WV), 839 87.5% 98.9% J Vet Med Sci 60:1043-5
Indirect ELISA (gp5), 1500 99.6% 90.1% J Virol Methods 54:1-13
Indirect ELISA (WV), 46 96% 26% Equin Vet J 40(2):182-3
Competitive blocking ELISA (M), 100 86% 100% CIMID. 26:251-60
Indirect ELISA (gp5), 800 96.75% 95.8% J Virol Methods 90:167-83
Competitive blocking ELISA (gp5), 675 90.7% 99% CJVR;64:38-43of respiratory disease, abortion, and infrequently, death in
young foals. OIE defines a horse as seropositive if its EAV virus
neutralization (VN) antibody titer is 1:4. The VN test can take
up to 72 hours to complete and requires certain laboratory fa-
cilities, equipment, and technical expertise to perform. Non-
viral cytotoxicity of sera from some horses vaccinated with
certain equine herpesvirus-1 vaccines can interfere with
interpretation of the test. Inter-laboratory variation in VN re-
sults due to variables such as reference virus used, type and cell
passage history has been reported. For these reasons an alter-
native serologic test is desirable, but none of the previously
reported ELISA tests (Table 1) have shown equivalent sensitivityand specificity compared to the VN test. With the aim of pro-
ducing a simpler and faster alternative to the OIE-prescribed
test, a cELISA was developed using EAV gp5-specific non-
neutralizing monoclonal antibody (MAb) 17B7. This cELISA was
validated with diverse sera (n¼2469) against the VN test. It had
a diagnostic sensitivity of 95.5% and a diagnostic specificity of
99.8% (JVDI. 25:182-8). The MAb-17B7 cELISA was further
validated in three EAV-testing laboratories including one OIE-
reference and two AAVLD-accredited laboratories: These
confirmed a test sensitivity of 99.5% and a specificity of 98.2%
(JVDI 25:727-35). As part of test validation, the following five
additional analyses were satisfactorily performed according to
the OIE-recommended validation protocol: 1. the primary assay
was calibrated with the OIE approved reference serum panel for
EVA, 2. repeatability of the assay was evaluated within and
between runs, 3. analytical specificity was evaluated using sera
specific for selected equine viruses, 4. analytical sensitivity was
evaluated with sera collected from horses vaccinated with the
modified live virus vaccine against EVA (Arvac®, Zoetis Animal
Health), and 5. Duration of the positive cELISA antibody was
evaluated following EVA vaccination. The analytical sensitivity
of the new cELISA was comparable to the VN test in that it
detected EAV-specific antibody as early as 6 days post-vacci-
nation. The duration of EAV-specific antibody detection by
cELISA was over six years post-vaccination. Based on the data
obtained, significant correlation was demonstrated between
the VN test and cELISA results (r2¼0.79, P<0.0001). The cELISA
was further improved using EAV purified by anion-exchange
membrane chromatography (JVDI accepted). This enhanced
cELISA was validated using diverse sera (n¼3255) at the
Maxwell H. Gluck Equine Research Center. The relative sensi-
tivity and specificity of this assay against a group of field sera
(n¼1851) was 99.6% (95% CI 99.4-100.0) and 98.7% (95% CI 98.3,
99.6), respectively, compared to the VN test (manuscript sub-
mitted). This rapid, highly sensitive and specific cELISA com-
pares very favorably to the VN test. It is USDA licensed and
should facilitate screening of horses intended for international
movement.045
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